Definium Therapeutics, Inc.

By person

16 insiders · 81 transactions

130×

Robert Barrow holds 130 times base salary in stock. $85.16M of shares against $655.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Barrow last reported holding, valued at $37.94, the price Common Shares was last bought or sold at on the open market here, on 3 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barrow Robert

Chief Executive Officer

$6.22K (2)

$4.25M (29) scheduled

−$4.25M

2,244,640

1.67%

$85.16M

—

Sullivan Mark

Chief Legal Officer

—

$1.35M (9) scheduled

−$1.35M

508,279

0.3783%

$19.28M

—

Karlin Daniel

Chief Medical Officer

—

$1.21M (27) scheduled

−$1.21M

803,699

0.5981%

$30.49M

—

Greenway Schond L.

Chief Financial Officer

—

$154.32K (6)

−$154.32K

211,057

0.1571%

$8.01M

—

Roberts Brandi

Chief Financial Officer

—

$135.68K (1) scheduled

−$135.68K

397,905

0.2961%

$15.10M

+43,245%

Wiley Matthew T.

Chief Commercial Officer

—

$129.10K (1) scheduled

−$129.10K

362,133

0.2695%

$13.74M

—

Liao Carrie

Chief Accounting Officer

—

$46.77K (3) scheduled

−$46.77K

144,923

0.1079%

$5.50M

—

GRYSKA DAVID W

Director

$38.86K (2)

—

+$38.86K

19,900

0.0148%

$755.01K

—

Hu Cynthia W.

Chief Legal Officer&Secretary

—

1,200,000

0.8931%

$45.53M

—

Halperin Wernli Miri

Executive President

—

202,405

0.1506%

$7.68M

—

Makes Brigid

Director

—

158,706

0.1181%

$6.02M

+501.8%

CRYSTAL ROGER

Director

—

24,289

0.0181%

$921.52K

—

Bruhn Suzanne Louise

Director

—

24,289

0.0181%

$921.52K

—

Vallone Carol A

Director

—

21,210

0.0158%

$804.71K

—

Krebs Andreas

Director

—

19,773

0.0147%

$750.19K

—

Adsett Roger

Director

—

3,555

0.0026%

$134.88K

—

Definium Therapeutics, Inc.

By person

Individual transactions

What was left out